Pricing Log in Create free account
Friday 6 November 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

REGN Healthcare Biotechnology

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024.

Revenue
+36.3%
EPS
+36.0%
Free cash flow
+3.85%
Total debt
−26.6%

Quarter to September 2026, against a year earlier

908.93 6.03 +0.67%
Market cap
$93.4B
P/E
19.2×
Fwd P/E
19.2×
Dividend yield
0.41%
F-score
5/9
Altman Z
7.49
Beneish M
−2.53
Dividend safety
77/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Regeneron Pharmaceuticals, Inc. (REGN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at a P/E ratio of 19.2×. Over the past ten years it has ranged from 7.3× (June 2022) to 152× (June 2015); the current reading is higher than 46% of that period. That is above the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 17.9× 2.73%
FY2024 17.4× (28.66%)
FY2023 24.4× 37.38%
FY2022 17.8× 115.25%
FY2021 8.3× (43.98%)
FY2020 14.7× (23.92%)
FY2019 19.4× 17.50%
FY2018 16.5× (51.36%)
FY2017 33.9× (24.87%)
FY2016 45.1× (48.77%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 16.1× 8.48%
Jun 2026 14.9× (18.10%)
Mar 2026 18.2× 1.49%
Dec 2025 17.9× 38.30%
43 more quarters

Against its own ten years

Low 7.3× High 152×
Ten-year median 20.3×
Current reading's percentile 51

P/E ratio against peers

Company P/E ratio
ROIV Roivant Sciences Ltd. compare n/m
MRNA Moderna, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
REGN Regeneron Pharmaceuticals, Inc. 19.2×
ARGX argenex SE compare 29.8×
VRTX Vertex Pharmaceuticals Incorporated compare 34.6×
GMAB Genmab A/S Sponsored ADR compare 41.7×
RPRX Royalty Pharma PLC compare 44.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 65.9×
Biotechnology industry median 10.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on REGN